Eliminating Immunosuppression in Regenerative Medicine

Apr 29, 2022PAO-04-22-R250-74

In an interview as part of Pharma's Almanac's the Road to 50 States campaign, Anthony Japour President and CEO at iTolerance, Inc., talks to Nigel Walker about the meaning and impact of ITolerance’s tagline “Pioneering Regenerative Medicine Without Immunosuppression.”